Marius Pharmaceuticals宣布与Hims & Hers Health Inc.合作,将扩大KYZATREX®(十一酸睾酮)CIII胶囊的可及性。KYZATREX是首个获得FDA批准的口服睾酮疗法,将在Hims & Hers Health Inc.平台上提供。
Marius Pharmaceuticals表示,KYZATREX将在未来几个月内通过Hims & Hers Health Inc.平台向患者提供。这项合作旨在为更多需要睾酮治疗的患者提供便利的治疗选择。
Marius Pharmaceuticals宣布与Hims & Hers Health Inc.合作,将扩大KYZATREX®(十一酸睾酮)CIII胶囊的可及性。KYZATREX是首个获得FDA批准的口服睾酮疗法,将在Hims & Hers Health Inc.平台上提供。
Marius Pharmaceuticals表示,KYZATREX将在未来几个月内通过Hims & Hers Health Inc.平台向患者提供。这项合作旨在为更多需要睾酮治疗的患者提供便利的治疗选择。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.